Description:
Kalorama Information’s The Market for Molecular Point-of-Care (mPOC), 2022 is an invaluable resource for stakeholders in the mPOC market, providing the most current and comprehensive analysis of the industry’s trends, technologies, and market dynamics, including market sizing, forecasting, trend analysis, and competitive landscape evaluation.
Report Highlights:
- Market Overview:
- Detailed analysis of the market for molecular point of care tests utilizing PCR or other molecular technologies known for their rapid turnaround times and suitability for near-patient settings.
- Examination of major industry players such as Abbott, Roche, and Quidel, along with many emerging competitors since our last report.
- Technological Advancements:
- Focus on mPOC systems that deliver faster and more accurate results compared to traditional lab-based tests and existing point of care systems.
- Exploration of ongoing developments and menu expansions within the mPOC segment.
- Defining mPOC:
- Clear definition of mPOC systems, characterized by their ability to perform DNA and RNA testing on compact devices designed for use outside of reference labs.
- Emphasis on the rapid result times, typically within the duration of an office visit or bedside consultation, facilitated by user-friendly cartridges and minimal preparation steps.
- Impact of COVID-19:
- In-depth analysis of how the COVID-19 pandemic has accelerated the adoption and development of mPOC systems.
- Coverage of the significant role rapid PCR testing has played during the pandemic, meeting the demand for timely and accurate diagnostics.
Market Insights:
- Data and Competitive Analysis:
- Detailed data on current mPOC systems and competitor landscape.
- Market size and growth projections from 2021 to 2026, including specific focus on the COVID-19 mPOC market.
- Breakdown of market share by vendor, geographic regions, and market segments.
- Segment Analysis:
- Detailed segmentation of the molecular point of care market, including respiratory and other applications.
- Analysis of the respiratory segment, covering specific conditions like Flu, RSV, and Strep.
- Geographic and segment breakouts of market data for 2021, including North America, Europe, APAC, and Rest of World (RoW).
Strategic Insights:
- Trends and Developments:
- Exploration of key trends such as menu expansion, disease statistics, and the competitive landscape amidst the COVID-19 crisis.
- Examination of immunoassay competition and enhancements, emerging markets, and recent journal studies on the efficacy of mPOC systems.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Molecular Point of Care Market, 2021-2026 (in millions $)
| Year | Revenues | Growth |
| 2021 | $XX Million | XX% |
| 2022 | $XX Million | XX% |
| 2023 | $XX Million | XX% |
| 2024 | $XX Million | XX% |
| 2025 | $XX Million | XX% |
| 2026 | $XX Million | XX% |
| CAGR | $XX Million | XX% |
Source: Kalorama Information
